US 12,357,365 B2
Vascular ablation
Edward Anderson, Maple Grove, MN (US); Adam Tschida, Brooklyn Park, MN (US); Randy Beyreis, Andover, MN (US); Scott Nelson, Mission Viejo, CA (US); JiChao Sun, Santa Rosa, CA (US); Laura Ortega, Fridley, MN (US); Joe Duerr, Andover, MN (US); Ae-Suk Pauling, St. Michael, MN (US); Dannah Dean, Minnetonka, MN (US); Doug Krone, Rogers, MN (US); and Brady Hatcher, Rogers, MN (US)
Assigned to Verge Medical Inc., Campbell, CA (US)
Filed by Verge Medical Inc., Campbell, CA (US)
Filed on May 23, 2023, as Appl. No. 18/322,456.
Application 18/322,456 is a continuation of application No. 17/697,739, filed on Mar. 17, 2022, granted, now 11,696,793.
Claims priority of provisional application 63/270,547, filed on Oct. 21, 2021.
Claims priority of provisional application 63/255,385, filed on Oct. 13, 2021.
Claims priority of provisional application 63/163,728, filed on Mar. 19, 2021.
Prior Publication US 2023/0310055 A1, Oct. 5, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 18/00 (2006.01); A61B 18/06 (2006.01); A61M 5/142 (2006.01); A61M 25/00 (2006.01); A61B 17/00 (2006.01); A61B 17/22 (2006.01); A61B 17/32 (2006.01); A61M 25/10 (2013.01)
CPC A61B 18/06 (2013.01) [A61M 5/14236 (2013.01); A61B 2017/00323 (2013.01); A61B 17/22004 (2013.01); A61B 17/32002 (2013.01); A61B 2018/00065 (2013.01); A61B 2018/0019 (2013.01); A61B 2018/00202 (2013.01); A61B 2018/00404 (2013.01); A61B 2218/002 (2013.01); A61M 25/0068 (2013.01); A61M 25/0082 (2013.01); A61M 2025/1086 (2013.01); A61M 2205/05 (2013.01); A61M 2205/3334 (2013.01); A61M 2210/12 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A vein ablation system, comprising:
a catheter having an elongated body;
an ablation device at a distal portion of the elongated body;
a control device at a proximal portion of the elongated body, the control device comprising a single actuator configured to simultaneously control an injection of a chemical agent into a target vessel and a defined movement of the ablation device, wherein a rate of the injection of the chemical agent into the target vessel and a rate of the defined movement of the ablation device is customizable relative to one another; and
a rate input configured to control the rate of the injection of the chemical agent into the target vessel and the rate of the defined movement of the ablation device.